MINI FUTURE SHORT - NOVO-NORDISK B | Market Closed - Nasdaq Stockholm 05:03:29 2024-05-03 am EDT | ||
| 704.8 SEK | +7.11% |
|
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
NOVO NORDISK A/S
Latest news about NOVO NORDISK A/S
Static data
| Product type | Certificat Turbo Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | NOVO NORDISK A/S |
| Issuer | Nordea |
| MINI S NOVO NOR | |
| ISIN | SE0021753258 |
| Date issued | 2024-04-10 |
| Strike | 1,290 kr |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | - kr |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | SEK |
Technical Indicators
| Highest since issue | 704.8 kr |
|---|---|
| Lowest since issue | 658 kr |
| Spread | 0.97 kr |
| Spread % | 0.18% |
Company Profile
Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows:
- diabetes and obesity treatment products (92.6%);
- rare disease treatment products (7.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc.
Net sales are distributed geographically as follows: Europe/Middle East/Africa (21.9%), the United States (54.9%), North America (3.9%), China (7.2%) and other (12.1%).
Sector
-
Consensus: Novo Nordisk A/S
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
927.3
DKK
Average target price
917.2
DKK
Spread / Average Target
-1.09%
- Stock Market
- Certificates
- MINI S NOVO NOR Certificat
